Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria

BACKGROUND: The effects of direct-acting antivirals (DAAs) on survival and recurrence rates after curative hepatocellular carcinoma (HCC) treatment in patients with hepatitis C virus (HCV) infection remain controversial. METHODS: This retrospective, multicenter study involved Child–Pugh class A pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochi, Hironori, Hiraoka, Atsushi, Hirooka, Masashi, Koizumi, Yohei, Amano, Michiko, Azemoto, Nobuaki, Watanabe, Takao, Yoshida, Osamu, Tokumoto, Yoshio, Mashiba, Toshie, Yokota, Tomoyuki, Abe, Masanori, Michitaka, Kojiro, Hiasa, Yoichi, Joko, Kouji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article—Liver, Pancreas, and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819935/
https://www.ncbi.nlm.nih.gov/pubmed/33278003
http://dx.doi.org/10.1007/s00535-020-01747-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819935/
https://www.ncbi.nlm.nih.gov/pubmed/33278003
http://dx.doi.org/10.1007/s00535-020-01747-y

Ejemplares similares